News Releases

News Release | U.S. PIRG Education Fund

McDonald’s commits to eliminating toxic ‘forever chemicals’ in food packaging globally

McDonald’s announced a commitment to eliminate per- and polyfluoroalkyl substances (PFAS) in food packaging used in its restaurants by 2025. PFAS are linked to kidney and liver problems, high cholesterol, reduced immune system function, and cancer.

News Release | US PIRG | Consumer Tips, COVID-19

Money for nothing: Paying the same car insurance while driving less during the pandemic

While COVID-19 is causing financial difficulties for tens of millions of Americans, auto insurers nationwide have made tens of billions of dollars in profit because consumers have driven significantly less during the pandemic.

News Release | OSPIRG Foundation | Consumer Protection

35th annual Trouble in Toyland report uncovers mislabeled and dangerous toys

PORTLAND --  OSPIRG Foundation's Trouble in Toyland report has helped identify dangerous toys for 35 years. But 2020 is unique, and as Americans have worked, learned and played from home to protect themselves from COVID-19, children could be more susceptible to certain toy-related hazards. 

News Release | OSPIRG | Consumer Tips

New report: COVID-19 pandemic worsens existing consumer problems with car buying

Consumer complaints to the Consumer Financial Protection Bureau (CFPB) regarding vehicle loans and leases have increased sharply during the coronavirus pandemic, according to a new report by OSPIRG and Frontier Group. The analysis suggests that consumers in Oregon and across the United States are facing abusive and deceptive practices from the automobile lending industry.  

News Release | OSPIRG | Health Care

Humira manufacturer’s efforts to block generic options challenged in court

The maker of Humira, the world’s best-selling drug, faces a new legal challenge over alleged anticompetitive tactics. Monday, the U.S. Public Interest Research Group (U.S. PIRG) filed an amicus brief in the 7th Circuit Court of Appeals arguing that AbbVie’s strategies of reverse payment settlements and creating “patent thickets” have delayed the entry of biologically similar generic drugs (biosimilars) onto the market, costing Americans billions of dollars. 

Pages

Subscribe to More News

Support us

Your tax-deductible donation supports OSPIRG Foundation’s work to educate consumers on the issues that matter, and the powerful interests that are blocking progress.

Learn More

You can also support OSPIRG Foundation’s work through bequests, contributions from life insurance or retirement plans, securities contributions and vehicle donations. 




OSPIRG Foundation is part of The Public Interest Network, which operates and supports organizations committed to a shared vision of a better world and a strategic approach to social change.